Corporate overview
| Company name | Bonac Corporation |
|---|---|
| Co-founder | Tadaaki Ohgi, Ph.D. Hirotake Hayashi |
| Director |
Hirotake Hayashi(President and CEO) Kihito Takahashi, M.D., Ph.D., MBA (Vice President and COO) Kyoko Miyoshi, M.Sc. (CFO) Nobuhiro Noro, Ph.D. (CSO) Takeo Kitayama (Executive Officer of SUMITOMO CHEMICAL Co., Ltd., External Director) Philippe Fauchet, OBE (External Director) Yoshihiko Matsuo (Audit and Supervisory Committee Member, External Director) Yoshiro Hori (Audit and Supervisory Committee Member, External Director) Tokuichiro Ide (Audit and Supervisory Committee Member, External Director) |
| Date of establishment | February 2010 |
| Capital | 3,877million yen （As of the end of December, 2017） |
| Business | RNA therapeutics Patent license Technology consulting |
| Head Office |
Fukuoka Bio Factory, 1488-4 Aikawa, Kurume Fukuoka 839-0861, JAPAN TEL: 81-942-32-6700 FAX: 81-942-32-4611 |
| Tokyo Branch |
The fifth Ujiie Building ♯502, 2-16-8,Uchikanda,Chiyoda-ku,Tokyo 101-0047,JAPAN TEL: 81-3-6206-8604 FAX: 81-3-6206-8704 |
